Canada markets closed

Aprea Therapeutics, Inc. (APRE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9500-0.0386 (-3.90%)
At close: 04:00PM EDT
0.9800 +0.03 (+3.16%)
After hours: 05:18PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
21,222
23,896
37,879
20,951
14,195
Selling General and Administrative
14,110
13,550
14,932
8,594
2,295
Total Operating Expenses
35,332
37,446
52,811
29,544
16,489
Operating Income or Loss
-35,332
-37,446
-52,811
-29,544
-16,489
Interest Expense
-
-
-
-
0.182
Total Other Income/Expenses Net
-68.37
317.402
-890.252
1,328
961.316
Income Before Tax
-35,395
-37,127
-53,479
-28,060
-15,528
Income from Continuing Operations
-35,395
-37,127
-53,479
-28,060
-15,528
Net Income
-35,395
-37,127
-53,479
-28,060
-15,528
Net Income available to common shareholders
-35,395
-37,127
-53,479
-28,060
-15,528
Basic EPS
-
-1.74
-2.53
-4.67
-1.65
Diluted EPS
-
-1.74
-2.53
-4.67
-1.65
Basic Average Shares
-
21,287
21,134
6,002
9,429
Diluted Average Shares
-
21,287
21,134
6,002
9,429
EBITDA
-
-37,175
-52,582
-29,374
-15,520